AU2001237178A1 - Endometriosis-related markers and uses thereof - Google Patents

Endometriosis-related markers and uses thereof

Info

Publication number
AU2001237178A1
AU2001237178A1 AU2001237178A AU3717801A AU2001237178A1 AU 2001237178 A1 AU2001237178 A1 AU 2001237178A1 AU 2001237178 A AU2001237178 A AU 2001237178A AU 3717801 A AU3717801 A AU 3717801A AU 2001237178 A1 AU2001237178 A1 AU 2001237178A1
Authority
AU
Australia
Prior art keywords
endometriosis
group
seq
cdnas
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237178A
Other languages
English (en)
Inventor
Soheyl Baban
Monique Bernard
Elana Cherry
Diane Gosselin
Patrice Hugo
Brigitte Malette
Pierre Miron
Charles Prive
Kamran Shazand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metriogene Biosciences Inc
Original Assignee
Procrea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procrea Biosciences Inc filed Critical Procrea Biosciences Inc
Publication of AU2001237178A1 publication Critical patent/AU2001237178A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AU2001237178A 2000-02-25 2001-02-26 Endometriosis-related markers and uses thereof Abandoned AU2001237178A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18506300P 2000-02-25 2000-02-25
US60185063 2000-02-25
US22574500P 2000-08-17 2000-08-17
US60225745 2000-08-17
PCT/CA2001/000245 WO2001062959A2 (en) 2000-02-25 2001-02-26 Endometriosis-related markers and uses thereof

Publications (1)

Publication Number Publication Date
AU2001237178A1 true AU2001237178A1 (en) 2001-09-03

Family

ID=26880752

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237178A Abandoned AU2001237178A1 (en) 2000-02-25 2001-02-26 Endometriosis-related markers and uses thereof

Country Status (10)

Country Link
US (3) US6777182B2 (de)
EP (1) EP1290218B8 (de)
JP (1) JP2003531580A (de)
AT (1) ATE365227T1 (de)
AU (1) AU2001237178A1 (de)
BR (1) BR0108685A (de)
CA (1) CA2399259A1 (de)
DE (2) DE60140580D1 (de)
ES (2) ES2336817T3 (de)
WO (1) WO2001062959A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100414637B1 (ko) * 2000-02-08 2004-01-13 (주)에스제이바이오메드 사람 미토콘드리아 아데닐레이트 키나제 이소자임들에대한 항체와 면역학적 제제 및 심장질환 진단키트
US6884578B2 (en) * 2000-03-31 2005-04-26 Affymetrix, Inc. Genes differentially expressed in secretory versus proliferative endometrium
US20060014166A1 (en) * 2004-01-27 2006-01-19 Yossi Cohen Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis
AU2003303576A1 (en) * 2002-05-14 2004-07-29 The Board Of Trustees Of The Leland Stanford Junior University Endometrial genes in endometrial disorders
US20050214836A1 (en) * 2002-08-30 2005-09-29 Oncotherapy Science, Inc. Method of diagnosing ovarian endometriosis
US20050100967A1 (en) * 2003-07-11 2005-05-12 Science & Technology Corporation @ Unm Detection of endometrial pathology
WO2005008251A2 (en) * 2003-07-11 2005-01-27 Praecis Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
CA2550900A1 (en) * 2003-12-23 2005-07-07 Mount Sinai Hospital Methods for detecting markers associated with endometrial disease or phase
US20060008876A1 (en) * 2004-07-07 2006-01-12 Shami A S E ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
US7943324B2 (en) * 2004-12-22 2011-05-17 The Trustees Of The University Of Pennsylvania Endometriosis markers
BRPI0613042A2 (pt) * 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
US8338111B2 (en) * 2006-12-22 2012-12-25 The Trustees Of The University Of Pennsylvania Endometriosis markers
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
JP2010540534A (ja) 2007-09-28 2010-12-24 イントレキソン コーポレーション 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用
AU2010219820A1 (en) 2009-03-06 2011-09-15 Mochida Pharmaceutical Co., Ltd. Method for diagnosing endometriosis and diagnostic kit for endometriosis
WO2010107734A2 (en) * 2009-03-16 2010-09-23 Ozgul Muneyyirci-Delale Methods for detecting endometriosis
GB201012662D0 (en) 2010-07-28 2010-09-15 Valirx Plc Method for detecting the presence of a gynaecological growth
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
GB201302837D0 (en) * 2013-02-19 2013-04-03 Univ Singapore Therapeutic Agents
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
CA2954895A1 (en) * 2014-07-17 2016-01-21 Celmatix Inc. Methods and systems for assessing infertility and related pathologies
EP3436580B1 (de) 2016-03-30 2021-03-17 Life Technologies AS Verbesserte verfahren und zusammensetzungen für nukleinsäureisolierung
WO2017201748A1 (zh) * 2016-05-27 2017-11-30 曾启瑞 一种检测子宫内膜异位症之方法与其应用
WO2019115829A1 (en) * 2017-12-15 2019-06-20 Endodiag Pépinière Génopole Entreprises Method of diagnosing endometriosis
EP3781945A4 (de) * 2018-04-20 2022-04-27 The Board of Regents of the University of Texas System Zusammensetzungen und verfahren zur behandlung von endometriose
JP7191361B2 (ja) * 2018-08-13 2022-12-19 学校法人 埼玉医科大学 産婦人科疾患の罹患可能性の判定を補助するための方法、産婦人科疾患の罹患可能性を診断するためのデータを収集する方法、及び産婦人科疾患の診断用キット
KR102255691B1 (ko) * 2018-12-14 2021-05-26 대한민국 돼지 발정주기 탐지용 자궁내막 유전자 및 그의 용도
US20220221472A1 (en) * 2019-04-26 2022-07-14 Chugai Seiyaku Kabushiki Kaisha Method for diagnosing endometriosis, disease state monitoring method, and kit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478725A (en) * 1992-06-12 1995-12-26 University Of Pennsylvania αv β3 integrin as a predictor of endometriosis
DE19824230A1 (de) * 1998-05-29 1999-12-02 Starzinski Powitz Anna Neues Endometriose-assoziiertes Gen
CA2299436A1 (en) * 1998-06-04 1999-12-09 Reprogen, Inc. Use of prothymosin in the diagnosis and treatment of endometriosis
EP1076723A2 (de) * 1998-06-04 2001-02-21 Reprogen, Inc. Verwendung von cathepsin s zur diagnose und behandlung von endometriose
KR100807441B1 (ko) * 2000-02-24 2008-02-25 동경 엘렉트론 주식회사 가스 누설 검지 시스템, 가스 누설 검지 방법 및 반도체제조 장치

Also Published As

Publication number Publication date
US20060057584A1 (en) 2006-03-16
US20020127555A1 (en) 2002-09-12
EP1290218A2 (de) 2003-03-12
WO2001062959A3 (en) 2003-01-03
US6777182B2 (en) 2004-08-17
JP2003531580A (ja) 2003-10-28
WO2001062959A2 (en) 2001-08-30
EP1290218B8 (de) 2007-10-03
US20120208869A1 (en) 2012-08-16
DE60129018D1 (de) 2007-08-02
ATE365227T1 (de) 2007-07-15
DE60129018T2 (de) 2008-02-21
BR0108685A (pt) 2003-12-30
EP1290218B1 (de) 2007-06-20
DE60140580D1 (de) 2009-12-31
ES2336817T3 (es) 2010-04-16
CA2399259A1 (en) 2001-08-30
US8148061B2 (en) 2012-04-03
ES2287100T3 (es) 2007-12-16
US8541173B2 (en) 2013-09-24

Similar Documents

Publication Publication Date Title
US8541173B2 (en) Endometriosis-related markers and uses thereof
EP2848700B1 (de) Marker für endometriosetumor
CN109666743B (zh) 一种宫颈癌分子标志物及其应用
EP1537243B1 (de) Verfahren zur diagnostik von eierstock endometriose
US20090087843A1 (en) Molecular markers
EP1484399A1 (de) Maus-spermatogenesegene, menschliche mit männlicher sterilität assoziierte gene und diese verwendendes diagnosesystem
EP1801236B1 (de) Endometriose Marker und Verwendung derselben
EP1682679B1 (de) Molekularer marker
CN114107461A (zh) 环状rna标志物及其在诊断和预测复发性流产病理妊娠中的应用
EP1354060B1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
EP1660676B1 (de) Diagnose des brustkrebsrisikos
CN110144352B (zh) 用于早期诊断骨科疾病的分子标志物
Gylfason et al. Quantitative DNA perturbations of p53 in endometriosis: analysis of American and Icelandic cases
US20030198961A1 (en) Determining cancer aggressiveness
CN114107462A (zh) 流产标志物及其在诊断和预测复发性流产病理妊娠中的应用
WO2005012565A1 (en) Genetic marker for coronary artery disease
EP1932926A2 (de) Verfahren zur Diagnostik von Eierstock Endometriose
Chan Application of Minimally-Invasive Uterine Fluid Aspiration to Identify Candidate Biomarkers of Endometrial Receptivity through a Transcriptomic Approach
van Kaam et al. Academisch Ziekenhuis Maastricht, Maastricht, The Netherlands
WO2004031386A1 (ja) アトピー性皮膚炎の検査方法
WO2005012564A1 (en) Genetic marker for coronary artery disease